Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Ruitailai Pharmaceutical Technology is a specialized pharmaceutical service provider based in Fuzhou, China, focusing on the research, development, and production of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company offers integrated CRO and CDMO services, assisting clients with process development, pilot-scale production, and large-scale commercial manufacturing of complex small molecules. Their technical expertise includes a wide range of chemical reactions and process optimization techniques designed to meet global regulatory standards. Ruitailai serves a diverse international clientele in the biotechnology and pharmaceutical sectors, providing high-quality chemical building blocks for drug discovery and development. The company operates modern facilities in the Fuzhou High-tech Zone, emphasizing quality control and efficient scale-up capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fujian Ruitailai Pharmaceutical Technology.